Pricing Log in Create free account

BioNexus Gene Lab Corp. (BGLC) vs 5E Advanced Materials, Inc. (FEAM)

BioNexus Gene Lab Corp. and 5E Advanced Materials, Inc. are both Specialty Chemicals companies. 5E Advanced Materials, Inc. is the larger, with a market value of $94.8M against $2.4M — 39.0× the size. 5E Advanced Materials, Inc. has the higher net margin (0.00% vs −82.4%) and the lower return on invested capital (−60.7% vs −37.2%). Across the 14 metrics below, 5E Advanced Materials, Inc. leads on 8 and BioNexus Gene Lab Corp. on 6.

Valuation

Metric BGLC FEAM Specialty Chemicals median
P/E n/m n/m 26.45
P/S 0.64 n/m 1.64
P/B 0.26 0.89 1.84
Price to free cash flow n/m n/m 21.25
EV/EBITDA 0.63 n/m 12.93
EV/Sales (0.47) n/m 1.90
Earnings yield (151.81%) (81.82%) 2.47%
Free cash flow yield (42.55%) (46.42%) 2.20%

Profitability

Metric BGLC FEAM Specialty Chemicals median
Gross margin 12.34% 0.00% 27.84%
Operating margin (79.62%) 0.00% 5.64%
Net margin (82.36%) 0.00% 4.26%
Free cash flow margin (27.30%) 0.00% 4.75%
Return on equity (33.66%) (67.42%) 3.73%
Return on assets (28.38%) (61.87%) 1.16%
Return on invested capital (37.16%) (60.65%) 3.21%

Growth

Metric BGLC FEAM Specialty Chemicals median
Revenue growth (TTM) (67.27%) — 7.03%
EPS growth (last fiscal year) (79.49%) 63.80% (8.48%)
Revenue growth, 5-year CAGR (8.20%) — 6.27%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGLC FEAM Specialty Chemicals median
Debt to equity 0.01 0.00 0.59
Current ratio 6.08 7.12 2.16
Net debt to EBITDA 1.49 0.89 2.03

Dividend

Metric BGLC FEAM Specialty Chemicals median
Dividend yield — — 1.84%
Payout ratio — — 0.40

Size

Metric BGLC FEAM Specialty Chemicals median
Market cap 2.43m 94.80m 1.95b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack